002414:SZSEWuhan Guide Infrared Co., Ltd. Analysis
Data as of 2026-06-06 - not real-time
CN¥12.53
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Wuhan Guide Infrared delivers robust revenue growth while maintaining healthy gross and operating margins. However, its trailing P/E ratio sits well above the industry average, and the forward P/E is markedly higher, indicating that earnings expectations have sharply deteriorated. The company carries a high debt‑to‑equity ratio despite a net cash position, adding leverage concerns in a capital‑intensive sector. No dividend is paid, so income‑focused investors have no yield cushion. On the technical side, the short‑term moving averages are almost flat, the RSI is in the oversold region, and the MACD histogram is negative, suggesting lingering bearish momentum. Trading volume has been on a downtrend, and the price is hovering just above a key support level while still below the nearest resistance.
Volatility has been elevated, and the stock’s beta is below one, reflecting moderate market sensitivity but heightened price swings. The sector—scientific and technical instruments—faces medium regulatory scrutiny in China, especially for advanced imaging technologies. Geographic concentration in the Chinese market adds medium‑high exposure to domestic economic cycles and policy shifts. Currency risk is modest given the CNY‑denominated shares, yet foreign investors must still consider exchange fluctuations. Liquidity appears adequate given the large market cap, but the recent decline in volume suggests a potential liquidity premium. Overall, the stock appears overvalued relative to its fundamentals, but its strong growth profile could support a valuation correction over a longer horizon.
Volatility has been elevated, and the stock’s beta is below one, reflecting moderate market sensitivity but heightened price swings. The sector—scientific and technical instruments—faces medium regulatory scrutiny in China, especially for advanced imaging technologies. Geographic concentration in the Chinese market adds medium‑high exposure to domestic economic cycles and policy shifts. Currency risk is modest given the CNY‑denominated shares, yet foreign investors must still consider exchange fluctuations. Liquidity appears adequate given the large market cap, but the recent decline in volume suggests a potential liquidity premium. Overall, the stock appears overvalued relative to its fundamentals, but its strong growth profile could support a valuation correction over a longer horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD momentum
- price near support
- high valuation relative to earnings
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- forward earnings decline
- elevated P/E ratio
- regulatory uncertainty
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- strong revenue growth trajectory
- high gross margins
- potential valuation re‑rating
Key Metrics & Analysis
Financial Health
Revenue Growth83.00%
Profit Margin18.68%
P/E Ratio54.5
ROE14.01%
ROA7.79%
Debt/Equity4.53
P/B Ratio7.2
Op. Cash FlowCN¥1.5B
Free Cash FlowCN¥151.3M
Industry P/E32.6
Technical Analysis
TrendNeutral
RSI31.0
SupportCN¥12.39
ResistanceCN¥15.14
MA 20CN¥13.66
MA 50CN¥13.65
MA 200CN¥13.76
MACDBearish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
Fair ValueCN¥1.31
Target PriceCN¥18.90
Upside/Downside50.84%
GradeOvervalued
TypeBlend
Risk Assessment
Beta0.62
Volatility30.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.